Asset Comparison and Correlation

Given investment horizon of 30 days, Generex Biotechnology Corporation is expected to generate 0.52 times more return on investment than Delcath. However, Generex Biotechnology Corporation is 1.93 times less risky than Delcath. It trades about -0.07 of its potential returns per unit of risk. Delcath Systems Inc. is currently generating about -0.27 per unit of risk. If you would invest 10.00 in Generex Biotechnology Corporation on April 26, 2012 and sell it today you would earn a total of 0.00 from holding Generex Biotechnology Corporation or generate 0.0% return on investment over 30 days.